DNA repair gene XRCC1 Arg399Gln polymorphism is associated with increased risk of uterine leiomyoma

Human Reproduction

Volumn 20, Issue 6, 2005, Pages 1586-1589

  Jeon, Yong Tark ^a   Kim, Jae Weon ^a   Park, Noh Hyun ^a   Song, Yong Sang ^a   Kang, Soon Beom ^a   Lee, Hyo Pyo ^a  

^a Seoul National University   (South Korea)

Author keywords

DNA repair gene XRCC1; Leiomyoma; Neoplasm; Polymorphism; Uterus

Indexed keywords

ARGININE; GLYCINE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN XRCC1; UNCLASSIFIED DRUG;

ADULT; AGE; ALLELE; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HYSTERECTOMY; KOREA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENARCHE; MYOMECTOMY; PARITY; PATHOGENESIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; UTERUS MYOMA;

EID: 20744440176     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh836     Document Type: Article

References (37)

1. Caldecott KW (2003) XRCC1 and DNA strand break repair. DNA Repair (Amst) 2,955-969.
2. Dal Cin P, Quade BJ, Neskey DM, Kleinman MS, Weremowicz S and Morton CC (2003) Intravenous leiomyomatosis is characterized by a der(14)t(12;14)(q15;q24). Genes Chromosomes Cancer 36,205-206.
3. Duell EJ, Wiencke JK, Cheng TJ, Varkonyi A, Zuo ZF, Ashok TD, Mark EJ, Wain JC, Christiani DC and Kelsey KT (2000) Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 21,965-971.
4. Flake GP, Andersen J and Dixon D (2003) Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 111,1037-1054.
5. Hahn WC and Weinberg RA (2002) Rules for making human tumor cells. N Engl J Med 347,1593-1603.
6. Haney AF (2000) Clinical decision making regarding leiomyomata: what we need in the next millenium. Environ Health Perspect 108 (Suppl 5), 835-839.
7. Hsieh YY, Chang CC, Tsai FJ, Tsai HD, Yeh LS, Lin CC and Tsai CH (2003) Estrogen receptor thymine-adenine dinucleotide repeat polymorphism is associated with susceptibility to leiomyoma. Fertil Steril 79,96-99.
8. Kelsey KT, Park S, Nelson HH and Karagas MR (2004) A population-based case-control study of the XRCC1 Arg399Gln polymorphism and susceptibility to bladder cancer. Cancer Epidemiol Biomarkers Prev 13, 1337-1341.
9. Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, Kado N, Tsukamoto K, Hasegawa G, Nakamura N and Honjo H (2001) Oestrogen receptor-alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata. Hum Reprod 16,51-55.
10. Krupa R and Blasiak J (2004) An association of polymorphism of DNA repair genes XRCC1 and XRCC3 with colorectal cancer. J Exp Clin Cancer Res 23,285-294.
11. Kurbanova M, Koroleva AG and Sergeev AS (1989) Genetic-epidemiologic analysis of uterine myoma: assessment of repeated risk. Genetika 25, 1896-1898.
12. Li Y, Marion MJ, Rundle A and Brandt-Rauf PW (2003) A common polymorphism in XRCC1 as a biomarker of susceptibility for chemically induced genetic damage. Biomarkers 8,408-414.
13. Ligon AH and Morton CC (2000) Genetics of uterine leiomyomata. Genes Chromosomes Cancer 28,235-245.
14. Lunn RM, Langlois RG, Hsieh LL, Thompson CL and Bell DA (1999) XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 59,2557-2561.
15. Luoto R, Kaprio J, Rutanen EM, Taipale P, Perola M and Koskenvuo M (2000) Heritability and risk factors of uterine fibroids - the Finnish Twin Cohort study. Maturitas 37,15-26.
16. Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, Willett WC and Hunter DJ (1997) Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 90,967-973.
17. Massart F, Becherini L, Gennari L, Facchini V, Genazzani AR and Brandi ML (2001) Genotype distribution of estrogen receptor-alpha gene polymorphisms in Italian women with surgical uterine leiomyomas. Fertil Steril 75,567-570.
18. Massart F, Becherini L, Marini F, Noci I, Piciocchi L, Del Monte F, Masi L, Falchetti A, Tanini A, Scarselli G et al. (2003) Analysis of estrogen receptor (ERalpha and ERbeta) and progesterone receptor (PR) polymorphisms in uterine leiomyomas. Med Sci Monit 9,BR25-BR30.
19. Matsuo K, Hamajima N, Suzuki R, Andoh M, Nakamura S, Seto M, Morishimae Y and Tajima K (2004) Lack of association between DNA base excision repair gene XRCC1 Gln399Arg polymorphism and risk of malignant lymphoma in Japan. Cancer Genet Cytogenet 149,77-80.
20. Mertens AC, Mitby PA, Radloff G, Jones IM, Perentesis J, Kiffmeyer WR, Neglia JP, Meadows A, Potter JD, Friedman D et al. (2004) XRCC1 and glutathione-S-transferase gene polymorphisms and susceptibility to radiotherapy-related malignancies in survivors of Hodgkin disease. Cancer 101,1463-1472.
21. Mort R, Mo L, McEwan C and Melton DW (2003) Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer. Br J Cancer 89,333-337.
22. Nelson HH, Kelsey KT, Mott LA and Karagas MR (2002) The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction. Cancer Res 62,152-155.
23. Nowell PC (1976) The clonal evolution of tumor cell populations. Science 194,23-28.
24. Olshan AF, Watson MA, Weissler MC and Bell DA (2002) XRCC1 polymorphisms and head and neck cancer. Cancer Lett 178,181-186.
25. Park JY, Lee SY, Jeon HS, Bae NC, Chae SC, Joo S, Kim CH, Park JH, Kam S, Kim IS et al. (2002) Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 11,23-27.
26. Rybicki BA, Conti DV, Moreira A, Cicek M, Casey G and Witte JS (2004) DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 13,23-29.
27. Sanyal S, Festa F, Sakano S, Zhang Z, Steineck G, Norming U, Wijkstrom H, Larsson P, Kumar R and Hemminki K (2004) Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25,729-734.
28. Sato F, Mori M, Nishi M, Kudo R and Miyake H (2002) Familial aggregation of uterine myomas in Japanese women. J Epidemiol 12,249-253.
29. Shen M, Hung RJ, Brennan P, Malaveille C, Donato F, Placidi D, Carta A, Hautefeuille A, Boffetta P and Porru S (2003) Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol Biomarkers Prev 12,1234-1240.
30. Smith TR, Miller MS, Lohman K, Lange EM, Case LD, Mohrenweiser HW and Hu JJ (2003) Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett 190,183-190.
31. Townsend DE, Sparkes RS, Baluda MC and McClelland G (1970) Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol 107,1168-1173.
32. Van Voorhis BJ, Romitti PA and Jones MP (2002) Family history as a risk factor for development of uterine leiomyomas. Results of a pilot study. J Reprod Med 47,663-669.
33. Wang Y, Spitz MR, Zhu Y, Dong Q, Shete S and Wu X (2003) From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst) 2,901-908.
34. Wu MT, Liu CL, Ho CK and Wu TN (2004) Genetic polymorphism of p53 and XRCC1 in cervical intraepithelial neoplasm in Taiwanese women. J Formos Med Assoc 103,337-343.
35. Yu HP, Zhang XY, Wang XL, Shi LY, Li YY, Li F, Su YH, Wang YJ, Lu B, Sun X et al. (2004) DNA repair gene XRCC1 polymorphisms, smoking, and esophageal cancer risk. Cancer Detect Prev 28,194-199.
36. Yu MW, Yang SY, Pan IJ, Lin CL, Liu CJ, Liaw YF, Lin SM, Chen PJ, Lee SD, Chen CJ et al. (2003) Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst 95,1485-1488.
37. Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L and Christiani DC (2003) Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomarkers Prev 12,359-365.